StonvexLoading…
StonvexStonvexStonvexCore line items from NRIM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2019 2019-06-30 | Q1 2019 2019-03-31 | Annual 2018 2018-12-31 | Q3 2018 2018-09-30 |
|---|---|---|---|---|
Revenue | $3.04M | $1.43M | $5.91M | $4.40M |
Operating Income | $5.41M | $5.47M | $24.07M | $6.39M |
Net Income | $4.26M | $4.31M | $20.00M | $5.26M |
EPS (Diluted) | $0.62 | $0.62 | $2.86 | $0.75 |
Total Assets | $1.55B | $1.52B | $1.50B | $1.50B |
Total Liabilities | $1.35B | $1.31B | $1.30B | $1.30B |
Cash & Equivalents | $70.83M | $78.93M | $77.54M | $70.18M |
Free Cash Flow OCF − CapEx | $-19.26M | $8.27M | $21.64M | $-4.07M |
Shares Outstanding | 6.73M | 6.88M | 6.88M | 6.88M |